Announcements Trials

Browse Landscape

Phase

Status

Terminated 2 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 6 Thoracic 4 Breast 4 Tumor-Agnostic 3 Other hematologic neoplasm 3 Sarcoma 2 Plasma cell 1 Other solid neoplasm 1 Myeloid 1 Lymphoid 1 Gynecologic 1 Genitourinary 1 Dermatologic 1

Conditions

Ovarian Neoplasms 1 Fallopian Tube Neoplasms 1

Interventions

Paclitaxel 264 Carboplatin 246 Cisplatin 153 Bevacizumab 104 Gemcitabine 78 Topotecan 77 liposomal doxorubicin 67 pembrolizumab 60 Docetaxel 56 Cyclophosphamide 50 Taxes 48 Radiotherapy 44 olaparib 43 Surveys and Questionnaires 43 Doxorubicin 43 Filgrastim 42 Brachytherapy 37 Drug Therapy 31 niraparib 28 Blood Specimen Collection 28 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 26 human papillomavirus vaccine, L1 type 16, 18 24 Peripheral Blood Stem Cell Transplantation 23 atezolizumab 22 Oxaliplatin 22 Pemetrexed 21 Nivolumab 21 Hyperthermic Intraperitoneal Chemotherapy 21 Etoposide 21 Immunoglobulin G 20

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × STA 9090 × Gynecologic × Clear all

NCT03783949 2025-06-11

EUDARIO

Universitaire Ziekenhuizen KU Leuven

Phase 2 Completed

122 enrolled 23 charts

Fallopian Tube Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡